TPO-RAs
IIT2022047
Approved small_molecule active
Quick answer
TPO-RAs for Primary Immune Thrombocytopenia (ITP) is a Approved program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Primary Immune Thrombocytopenia (ITP)
- Phase
- Approved
- Modality
- small_molecule
- Status
- active